Literature DB >> 12758197

Human immunity to M. tuberculosis: T cell subsets and antigen processing.

W H Boom1, David H Canaday, Scott A Fulton, Adam J Gehring, Roxana E Rojas, Marta Torres.   

Abstract

A hallmark of M. tuberculosis infection is the ability of most (90-95%) healthy adults to control infection through acquired immunity, in which antigen specific T cells and macrophages arrest growth of M. tuberculosis bacilli and maintain control over persistent bacilli. In addition to CD4+ T cells, other T cell subsets such as, gammadelta, CD8+ and CD1-restricted T cells have roles in the immune response to M. tuberculosis. A diverse T cell response allows the host to recognize a wider range of mycobacterial antigens presented by different families of antigen-presenting molecules, and thus greater ability to detect the pathogen. Macrophages are key antigen presenting cells for T cells, and M. tuberculosis survives and persists in this central immune cell. This is likely an important factor in generating this T cell diversity. Furthermore, the slow growth and chronic nature of M. tuberculosis infection results in prolonged exposure to antigens, and hence further T cell sensitization. The effector mechanisms used by T cells to control M. tuberculosis are poorly understood. To survive in macrophages, M. tuberculosis has evolved mechanisms to block immune responses. These include modulation of phagosomes, neutralization of macrophage effector molecules, stimulating the secretion of inhibitory cytokines, and interfering with processing of antigens for T cells. The relative importance of these blocking mechanisms likely depends on the stage of M. tuberculosis infection: primary infection, persistence, reactivation or active tuberculosis. The balance of the host-pathogen interaction in M. tuberculosis infection is determined by the interaction of T cells and infected macrophages. The outcome of this interaction results either in control of M. tuberculosis infection or active disease. A better understanding of this interaction will result in improved approaches to treatment and prevention of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12758197     DOI: 10.1016/s1472-9792(02)00054-9

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  52 in total

1.  Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Authors:  Qing Li; Xuedong Ding; Jeremy J Thomas; Clifford V Harding; Nicole D Pecora; Assem G Ziady; Samuel Shank; W Henry Boom; Christina L Lancioni; Roxana E Rojas
Journal:  J Leukoc Biol       Date:  2011-12-07       Impact factor: 4.962

2.  Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis.

Authors:  Jing Jiang; Xianyuan Wang; Xinjing Wang; Zhihong Cao; Yanhua Liu; Mei Dong; Aihua Tong; Xiaoxing Cheng
Journal:  J Clin Immunol       Date:  2010-07       Impact factor: 8.317

3.  New TB vaccines: is there a requirement for CD8 T cells?

Authors:  W Henry Boom
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response.

Authors:  M Lichtner; R Rossi; F Mengoni; S Vignoli; B Colacchia; A P Massetti; I Kamga; A Hosmalin; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

5.  Neutralization of tumor necrosis factor alpha suppresses antigen-specific type 1 cytokine responses and reverses the inhibition of mycobacterial survival in cocultures of immune guinea pig T lymphocytes and infected macrophages.

Authors:  Hyosun Cho; David N McMurray
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB.

Authors:  Crystal Y Chen; Dan Huang; Shuyu Yao; Lisa Halliday; Gucheng Zeng; Richard C Wang; Zheng W Chen
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

7.  Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.

Authors:  Anja Weinreich Olsen; Michael Theisen; Dennis Christensen; Frank Follmann; Peter Andersen
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

8.  CD3+ICOS+ T cells show differences in the synthesis of nitric oxide, IFN-γ, and IL-10 in patients with pulmonary tuberculosis or in healthy household contacts.

Authors:  Carmen Lara-Rodríguez; Noé Alvarado-Vásquez; Demetrio Bernal; Patricia Gorocica; Edgar Zenteno; Ricardo Lascuraín
Journal:  Clin Exp Med       Date:  2015-08-08       Impact factor: 3.984

9.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

10.  Cytotoxic effect of recombinant Mycobacterium tuberculosis CFP-10/ESAT-6 protein on the crucial pathways of WI-38 cells.

Authors:  Kun-Nan Tsai; Err-Cheng Chan; Tsung-Yeh Tsai; Kuei-Tien Chen; Chun-Yu Chen; Kenneth Hung; Chung-Ming Chen
Journal:  J Biomed Biotechnol       Date:  2009-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.